Lee M J, Heywood N, Sagar P M, Brown S R, Fearnhead N S
Department of General Surgery, Sheffield Teaching Hospitals, Sheffield, UK.
Department of Oncology and Metabolism, Medical School, University of Sheffield, Sheffield, UK.
Colorectal Dis. 2017 Mar;19(3):266-273. doi: 10.1111/codi.13462.
Around one-third of patients with Crohn's disease are affected by Crohn's fistula-in-ano (pCD). It typically follows a chronic course and patients undergo long-term medical and surgical therapy. We set out to describe current surgical practice in the management of pCD in the UK.
A survey of surgical management of pCD was designed by an expert group of colorectal surgeons and gastroenterologists. This assessed acute, elective, multidisciplinary and definitive surgical management. A pilot of the questionnaire was undertaken at the 2015 meeting of the Digestive Disease Federation. The survey was refined and distributed nationally through the trainee collaborative networks.
National rollout obtained responses from 133 of 179 surgeons approached (response rate 74.3%). At first operation, 32% of surgeons would always consider drainage of sepsis and 31.1% would place a draining seton. At first elective operation, 66.6% would routinely insert of draining seton, and 84.4% would avoid cutting seton. An IBD multidisciplinary team was available to 87.6% of respondents, although only 25.1% routinely discussed pCD patients. Anti-tumour necrosis factor-alpha therapy was routinely considered by 64.2%, although 44.2% left medical management to gastroenterologists. Common definitive procedures were removal of the seton only (70.7%), fistulotomy (57.1%), advancement flap (38.9%), fistula plug (36.4%) and ligation of intersphincteric track (LIFT) procedure (31.8%). Indications for diverting stoma or proctectomy were intractable sepsis, incontinence and poor quality of life.
This survey has demonstrated areas of common practice, but has also highlighted divergent practice including choices of definitive surgery and multimodal management. Practical guidelines are required to support colorectal surgeons in the UK.
约三分之一的克罗恩病患者会受到克罗恩氏肛管瘘(pCD)的影响。该病通常病程呈慢性,患者需接受长期的药物和手术治疗。我们旨在描述英国目前pCD治疗中的手术实践情况。
由结直肠外科医生和胃肠病学家组成的专家组设计了一项关于pCD手术治疗的调查。该调查评估了急性、择期、多学科及确定性手术治疗。问卷在2015年消化疾病联合会会议上进行了预试验。经完善后通过实习医生协作网络在全国范围内分发。
在全国推广过程中,179名受访外科医生中有133名回复(回复率74.3%)。在首次手术时,32%的外科医生总会考虑引流脓毒症,3¹.¹%会放置引流挂线。在首次择期手术时,66.6%会常规插入引流挂线,84.4%会避免切断挂线。87.6%的受访者所在单位设有炎症性肠病多学科团队,不过只有25.1%会常规讨论pCD患者。64.2%的医生会常规考虑使用抗肿瘤坏死因子-α治疗,尽管44.2%将药物治疗留给胃肠病学家。常见的确定性手术包括仅拆除挂线(70.7%)、瘘管切开术(57.1%)、推进皮瓣术(38.9%)、瘘管封堵术(36.4%)和括约肌间瘘管结扎术(LIFT手术,31.8%)。行转流性造口术或直肠切除术的指征为难治性脓毒症、大便失禁和生活质量差。
本次调查展示了常见的手术实践领域,但也凸显了存在差异的实践情况,包括确定性手术的选择和多模式治疗。英国需要实用指南来支持结直肠外科医生。